HLB Panagene Inc

KRX • Healthcare • Biotechnology • Quote as of 10/23/2026 15:30

Company Profile

IndustryBiotechnology

SectorHealthcare

ExchangeKRX

Market Capitalization80,767 mln

Float30.79 mln

Piotroski F-Score

4 / 9

Borderline

Beneish M-Score

-2.06

Caution advised

Relative Strength

9 / 100

Severely lagging

Debt / Equity

0.08

Debt-free

Pre-Tax Margin

-22%

Deeply loss-making

ROE

-4.48

Negative

Key Fundamentals

EPS-72.14

ROE-4.48

ROIC-5.24

ROA-3.51

EBITDA, mln-805

EV / EBITDA-49.37

EV / EBIT-15.80

Revenue, mln14,708

EV / Revenue2.70

Quote Details

Last 1,393.00

Change -1 (-0.07%)

Open 1,381.00

Volume 152,844

Turnover 212,911,696

Average Volume 1,176,306

Financial Ratios

Pre-Tax Profit Margin-22

Current Ratio4.94

Price / Book0.79

Price / Tangible Book0.83

Debt / Equity0.08

Price / Sales3.93

Financial Strength

Altman Z-Score4.77

Piotroski F-Score 4 / 9

Beneish M-Score-2.06

Price to Intrinsic Value0.84

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-0.5%	75 / 100
1 Month	23.6%	97 / 100
2 Months	29.34%	93 / 100
6 Months	-45.59%	17 / 100
1 Year	-15.42%	44 / 100